Cymbalta

CymbaltaCymbalta side effects Cymbalta withdrawal Cymbalta dosage Cymbalta and pregnancy
Cymbalta
Cymbalta
Fibromyalgia treatment with Cymbalta

When it comes to drug administration, Cymbalta medication must be used very carefully. Careless and badly administered medication of Cymbalta can lead to rampant side-effects which however, are easily curable according to a good number of sources. Important factors to be cautious about are the user's health condition and medical history. Cymbalta primarily works in order to escalate the serotonin and norepinephrine levels in the brain and the spinal chord causing an improvement of mood. It is used to treat general anxiety disorders, stress urinary inconsistency, diabetic and body pains.

Before starting consumption of Cymbalta:

Health/behavorial conditions that discourage the user from Cymbalta medication are:

  • Glaucoma
  • Seizures or Epilepsy
  • Liver Problems
  • Blood sugar
  • Suicidal tendency (especially for young adults) or a history of drug/alcohol abuse.
  • Pregnancy - doctors should be consulted even if pregnancy is planned in the future as duloxetine is a harmful chemical for the fetus.

Medicines that should not be administered with Cymbalta:

  • Mellaril
  • Monoamine Oxidase inhibitor (MAOI), such as Marplan (or Nardil or Aziltec) - a 14-day gap before starting the Cymbalta course and a 5-day gap before continuing MAOI is necessary.

It is also important to mention to your doctor in case you are allergic to any drug.

During Cymbalta medication:

Suicidal behavior, especially amongst young adults using Cymbalta has been an issue of major concern. Experts have found that there seems to be a 1.5 - 2-fold increase in suicidal behavior in young adults. It is the opinion of medical experts, however, that suicidal feelings or emotions are almost unavoidable in the initial phases of any antidepressant medication. Therefore it is necessary that the administering doctor regularly visits the patient during the first 12 weeks of treatment. Nurses and families should be alert to any sort of change in the behavior or mood of the patient.

It is important that the user realizes that Cymbalta is a drug meant for slow distribution through the body. The prescribed amount is important. Overdosing this drug is not advised under any circumstance unless you consult the doctor about your complaints. On an average, about 4 weeks or longer should be given for the symptoms to show improvement. Cymbalta should be administered at a total dose of 40mg (20mg BID) to 60mg (30mg BID) per day irrespective of meals. For discontinuation a gradual tapering of dosage is advisory. Doctors should be consulted for deciding the tapering doses.

Cymbalta Availability:

Delayed release capsules

  • 20mg capsules - opaque, green with "Lilly 3235 20mg"
  • 30mg capsules - opaque, in both, white and blue with "Lilly 3240 30mg"
  • 60mg capsules - opaque, in both, green and blue with "Lilly 3237 60mg"

As a Cymbalta user, one must remember certain vital habits:

  • Maintaining regularity with consumption of the drug brings about best results.
  • Even if side-effects are wearing you down, it is important that you do not miss any dosage.
  • Even if you miss a dosage, take it as soon as possible. However it is important that you do not take two dosages at the same time. You can wait for the time of the next dosage and get back to the old routine.
  • Storing Cymbalta - the ideal temperature for storing Cymbalta is 25 degrees C. However, for brief periods Cymbalta can be stored between 15 to 30 degrees C. Cymbalta should be stored away from heat, light and moisture, and kept away from children and pets.

Important symptoms (side effects) to be noted while under the medication of Cymbalta (these symptoms must be discussed with the health service provider immediately):

  • Itching.
  • Liver problems - have earlier proved to be fatal.
  • High fever (unexplained).
  • Confusion, memory problems and stiff muscles.
  • Headaches, concentration problems - occurs mostly due to low sodium levels.
  • Dizziness - this occurs mostly due to pressure fluctuations.
  • Speech problems.
  • Cardiac problems and excessive sweating.

Dosage and recovery trends:

Dosing Cybalta medication

A patient is usually expected to respond to Cymbalta in 4-8 weeks. However, if the patient does not respond, the medication is supposed to be continued for another 6 months of a 9-12 month treatment period. Patients with a chance of relapse from the dosage efficacy are usually maintained at effective dosage beyond six months and if necessary indefinitely. The dosage amounts depend on the patient's condition or complaint.

Patients with a mild renal impairment (CLcr > = 30mL/min) need no regulation of Cymbalta dosage. However, patients with CLcr < 30mL/min or even hepticimpairment are not considered fit to consume Cymbalta.

For general safety - Users of Cymbalta while under its influence have been found to be sleepy and dizzy. It is therefore advised that users while on antidepressants should avoid driving or operating hazardous machines.